ADAP
Invesco’s Adaptimmune Therapeutics ADAP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-78,031
| Closed | -$15.4K | – | 3760 |
|
2025
Q1 | $15.4K | Buy |
78,031
+14,696
| +23% | +$2.9K | ﹤0.01% | 3738 |
|
2024
Q4 | $34.1K | Buy |
63,335
+28,526
| +82% | +$15.4K | ﹤0.01% | 3705 |
|
2024
Q3 | $33.1K | Buy |
34,809
+66
| +0.2% | +$63 | ﹤0.01% | 3708 |
|
2024
Q2 | $33.9K | Buy |
+34,743
| New | +$33.9K | ﹤0.01% | 3841 |
|
2023
Q4 | – | Sell |
-45,906
| Closed | -$35.8K | – | 3813 |
|
2023
Q3 | $35.8K | Buy |
45,906
+10,914
| +31% | +$8.51K | ﹤0.01% | 3804 |
|
2023
Q2 | $32.4K | Buy |
+34,992
| New | +$32.4K | ﹤0.01% | 3827 |
|
2020
Q2 | – | Sell |
-17,448
| Closed | -$47K | – | 3597 |
|
2020
Q1 | $47K | Buy |
+17,448
| New | +$47K | ﹤0.01% | 3568 |
|